Clinical Development

In the evolving landscape of drug development and life sciences investing, driving clinical innovation has long been an industry challenge. The high cost and complexity of clinical trial design, execution, and development (spanning novel drug candidates to med‑tech solutions) have historically concentrated activity among a small number of large pharmaceutical companies. These firms benefit from substantial resources, scale, and established clinical networks, factors that can create significant barriers to entry for emerging participants.

​

However, with the rapid advancement of AI, offers the opportunity to disrupt this established model. Created through the unique vision of LGC, we plan to launch our own AI driven Clinical Research - Management Organisation Platform. This pioneering approach is intended to combine AI with comprehensive Real-World Data (RWD) with analytics to create a decentralised, adaptive, and highly innovative strategy to clinical development. The platform will be developed to redefine clinical trial time and site efficiency, enhance trial patient outcomes and pave the way for more accessible cost-effective solutions.